Blood Glucose Response of a Low-Carbohydrate Oral Nutritional Supplement with Isomaltulose and Soluble Dietary Fiber in Individuals with Prediabetes: A Randomized, Single-Blind Crossover Trial
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
A high-energy-type oral dietary supplement (ONS), with a low proportion of available carbohydrate (LC-ONS), which contains a slowly digestible carbohydrate, isomaltulose, and is fortified with soluble dietary fiber, was newly developed for individuals with diabetes or prediabetes. This study aimed to evaluate the impact of LC-ONS on blood glucose levels after ingestion in individuals with prediabetes. A single-blind, randomized crossover clinical trial was performed on 20 individuals with prediabetes. After overnight fasting, all subjects ingested one serving (200 kcal/125 mL) of either LC-ONS (40% energy proportion of available carbohydrates) or standard ONS (ST-ONS, 54% energy proportion of available carbohydrates) on two separate days. The incremental area under the curve of blood glucose levels for 120 min was significantly lower after LC-ONS ingestion compared to ST-ONS (2207 ± 391 mg/dL·min (least mean square value ± standard error) and 3735 ± 391 mg/dL·min, respectively; p < 0.001). The LC-ONS showed significantly lower blood glucose levels than the ST-ONS at all time points, except at baseline. Similarly, the incremental area under the curve of plasma insulin was significantly lower after LC-ONS ingestion. These results suggest that LC-ONS is useful as an ONS for energy supply in individuals with postprandial hyperglycemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Gut microbiota ferment fibers into short-chain fatty acids (SCFAs) like acetate, propionate, and butyrate, which provide energy to colon cells and benefit metabolic health and gut barrier”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [130]
Experimental — accuracy not yet measuredIn the citing paper
“In diabetic patients, a high-fiber diet compared with a standard diet improved microbiota composition, lowered HbA1c, and increased circulating GLP-1 [130]”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [130]
In the citing paper
“SCFAs can stimulate GLP-1 and peptide YY (PYY) secretion by L-cells and leptin release by adipose tissue, while reduced SCFAs production is linked to T2DM's pathophysiology [130,242]”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013
Wang, L., Gao, P., Zhang, M., Huang, Z., Zhang, D., Deng, Q., Li, Y., Zhao, Z., Qin, X., Jin, D., et al. (2017) · JAMA · doi:10.1001/jama.2017.7596 · Cited by 1,844 · cited 1×
“In developed countries, the prevalence of diabetes [4,5] and prediabetes [6,7] is higher in older people than in younger people.”
BackgroundGut microbial metabolites in obesity, NAFLD and T2DM
Canfora, E. E., Meex, R. C. R., Venema, K., & Blaak, E. E. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0156-z · Cited by 1,493 · cited 1×
“Furthermore, soluble dietary fiber was reported to ameliorate insulin resistance caused by chronic inflammation by improving dysbiosis of the intestinal microflora in continuous ingestion [40,41], as well as their postprandial blood glucose-lowering effects in one-shot ingestion.”
BackgroundPostprandial Hyperglycemia and Diabetes Complications
Ceriello, A. (2005) · Diabetes · doi:10.2337/diabetes.54.1.1 · Cited by 945
Protein and energy supplementation in elderly people at risk from malnutrition
Milne, A. C., Potter, J., Vivanti, A., & Avenell, A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003288.pub3 · Cited by 849 · cited 1×
“ONS were shown to improve the nutritional status of malnourished older individuals [2].”
BackgroundXu, G., Liu, B., Sun, Y., Du, Y., Snetselaar, L. G., Hu, F. B., & Bao, W. (2018) · BMJ · doi:10.1136/bmj.k1497 · Cited by 545 · cited 1×
“In developed countries, the prevalence of diabetes [4,5] and prediabetes [6,7] is higher in older people than in younger people.”
BackgroundJapanese clinical practice guideline for diabetes 2019
Araki, E., Goto, A., Kondo, T., Noda, M., Noto, H., Origasa, H., Osawa, H., Taguchi, A., Tanizawa, Y., Tobe, K., et al. (2020) · Diabetology International · doi:10.1007/s13340-020-00439-5 · Cited by 545
Isomaltulose (Palatinose®): a review of biological and toxicological studies
Lina, B. A. R., Jonker, D., & Kozianowski, G. (2002) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(02)00105-9 · Cited by 293 · cited 1×
“Isomaltulose, a disaccharide consisting of glucose and fructose linked by α-1,6 glycosidic linkages, is a low glycemic response carbohydrate [19,20].”
BackgroundGeidl-Flueck, B., Hochuli, M., Németh, Á., Eberl, A., Derron, N., Köfeler, H. C., Tappy, L., Berneis, K., Spinas, G. A., & Gerber, P. A. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.02.027 · Cited by 238 · cited 1×
“Chronic intake of fructose and sucrose is associated with the development of the metabolic syndrome and obesity [26,27].”
Background12. Older Adults:Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s012 · Cited by 219
Wang, Q., Zhang, X., Fang, L., Guan, Q., Guan, L., & Li, Q. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198343 · Cited by 167 · cited 1×
“In developed countries, the prevalence of diabetes [4,5] and prediabetes [6,7] is higher in older people than in younger people.”
BackgroundYu, K., Ke, M., Li, W., Zhang, S., & Fang, X. (2014) · PubMed · doi:10.6133/apjcn.2014.23.2.01 · Cited by 162 · cited 1×
“The results of LC-ONS found in this study are presumed to be found in patients with diabetes as well because the postprandial blood glucose-lowering effects of isomaltulose [35] and soluble dietary fibers [36,37] were found in patients with diabetes in previous studies.”
ResultOptimizing nutrition in older people
Clegg, M. E., & Williams, E. A. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.04.001 · Cited by 142 · cited 1×
“Older people are at an increased risk of malnutrition owing to decreased activity, loss of appetite, and diseases [1].”
BackgroundFructose-containing caloric sweeteners as a cause of obesity and metabolic disorders
Tappy, L. (2018) · Journal of Experimental Biology · doi:10.1242/jeb.164202 · Cited by 126 · cited 1×
“Chronic intake of fructose and sucrose is associated with the development of the metabolic syndrome and obesity [26,27].”
BackgroundWada, T., Sugatani, J., Terada, E., Ohguchi, M., & Miwa, M. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf048711u · Cited by 125 · cited 1×
“Resistant maltodextrin and inulin contained in the LC-ONS are soluble dietary fibers that inhibit the absorption of carbohydrates ingested simultaneously and suppress postprandial blood glucose elevation [21,22].”
BackgroundLivesey, G., & Tagami, H. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26842 · Cited by 115
Galgani, J., Aguirre, C., & Díaz, E. (2006) · Nutrition Journal · doi:10.1186/1475-2891-5-22 · Cited by 110 · cited 1×
“Suppression of postprandial insulin secretion was observed with other ONS for diabetes [10,15,31] and low-glycemic index diets [32].”
BackgroundRao, M., Gao, C., Xu, L., Jiang, L., Zhu, J., Chen, G., Law, B. Y. K., & Xu, Y. (2019) · Journal of Diabetes Research · doi:10.1155/2019/5101423 · Cited by 104 · cited 1×
“Furthermore, soluble dietary fiber was reported to ameliorate insulin resistance caused by chronic inflammation by improving dysbiosis of the intestinal microflora in continuous ingestion [40,41], as well as their postprandial blood glucose-lowering effects in one-shot ingestion.”
BackgroundInduction of Hypertriglyceridemia by a Low-Fat Diet
GINSBERG, H., OLEFSKY, J. M., KIMMERLING, G., CRAPO, P., & REAVEN, G. M. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-42-4-729 · Cited by 103 · cited 1×
“Diets with a low AC energy ratio have a low postprandial blood glucose rise [18].”
BackgroundChanges in blood glucose and insulin after an oral palatinose administration in normal subjects.
KAWAI, K., OKUDA, Y., & YAMASHITA, K. (1985) · Endocrinologia Japonica · doi:10.1507/endocrj1954.32.933 · Cited by 100 · cited 1×
“Isomaltulose, a disaccharide consisting of glucose and fructose linked by α-1,6 glycosidic linkages, is a low glycemic response carbohydrate [19,20].”
BackgroundEckel, R. H., Hanson, A. S., Chen, A. Y., Berman, J. N., Yost, T. J., & Brass, E. P. (1992) · Diabetes · doi:10.2337/diab.41.5.641 · Cited by 89 · cited 1×
“However, medium-chain fatty acids, which comprise 45% of the constituent fatty acids of LC-ONS, are known to be less likely than long-chain fatty acids to accumulate ectopic fat [38] and to increase insulin sensitivity [39].”
BackgroundMadsbad, S. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.09.019 · Cited by 84 · cited 1×
“Postprandial hyperglycemia is considered a risk factor for the onset of cardiovascular disease [8] and microvascular complications [9] in patients with diabetes.”
BackgroundLivesey, G., & Tagami, H. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.26842 · Cited by 74 · cited 1×
“Resistant maltodextrin and inulin contained in the LC-ONS are soluble dietary fibers that inhibit the absorption of carbohydrates ingested simultaneously and suppress postprandial blood glucose elevation [21,22].”
BackgroundTakeshi, K., Nakagawa, S., Jo, S.-R., Kanazawa, Y., Iwamoto, Y., Kobayashi, M., Nanjo, K., Sasaki, A., & Kadowaki, T. (1999) · 糖尿病 · Cited by 68
Arai, H., Mizuno, A., Sakuma, M., Fukaya, M., Matsuo, K., Muto, K., Sasaki, H., Matsuura, M., Okumura, H., Yamamoto, H., et al. (2006) · Metabolism · doi:10.1016/j.metabol.2006.09.005 · Cited by 65 · cited 1×
“The ONS with 56% of the carbohydrate replaced with isomaltulose showed a 55% lower postprandial blood glucose iAUC than the standard ONS with similar proportions of macronutrients [12].”
BackgroundSex and age differences in prevalence and risk factors for prediabetes in Mexican-Americans
Vatcheva, K. P., Fisher‐Hoch, S. P., Reininger, B. M., & McCormick, J. B. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107950 · Cited by 53 · cited 1×
“In developed countries, the prevalence of diabetes [4,5] and prediabetes [6,7] is higher in older people than in younger people.”
BackgroundMetabolic Effects of Replacing Sucrose by Isomaltulose in Subjects With Type 2 Diabetes
Brunner, S., Holub, I., Theis, S., Gostner, A., Melcher, R., Wolf, P., Amann-Gassner, U., Scheppach, W., & Hauner, H. (2012) · Diabetes Care · doi:10.2337/dc11-1485 · Cited by 41
Arai, H., Mizuno, A., Matsuo, K., Fukaya, M., Sasaki, H., Arima, H., Matsuura, M., Taketani, Y., Doi, T., & Takeda, E. (2004) · Metabolism · doi:10.1016/j.metabol.2004.03.004 · Cited by 38 · cited 1×
“Rats continuously fed with isomaltulose suppressed the increase in abdominal fat accumulation [29].”
Backgroundden Bosch, J. D. V., van den Berg, S. A. A., Bijland, S., Voshol, P. J., Havekes, L. M., Romijn, H. A., Hoeks, J., van Beurden, D., Hesselink, M. K. C., Schrauwen, P., et al. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.03.004 · Cited by 37 · cited 1×
“However, medium-chain fatty acids, which comprise 45% of the constituent fatty acids of LC-ONS, are known to be less likely than long-chain fatty acids to accumulate ectopic fat [38] and to increase insulin sensitivity [39].”
BackgroundGarcía-Rodríguez, C. E., Mesa, M. D., Olza, J., Buccianti, G., Pérez, M., Moreno‐Torres, R., de la Cruz, A. P., & Gil, Á. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0462-x · Cited by 36
Lin, C.-H., Chang, D.-M., Wu, D.-J., Peng, H.-Y., & Chuang, L. (2015) · Medicine · doi:10.1097/md.0000000000001332 · Cited by 36 · cited 1×
“The results of LC-ONS found in this study are presumed to be found in patients with diabetes as well because the postprandial blood glucose-lowering effects of isomaltulose [35] and soluble dietary fibers [36,37] were found in patients with diabetes in previous studies.”
ResultKeyhani‐Nejad, F., Kemper, M., Schüler, R., Pivovarova‐Ramich, O., Rudovich, N. N., & Pfeiffer, A. F. H. (2015) · Diabetes Care · doi:10.2337/dc15-1891 · Cited by 30
Lansink, M., Laere, K. M. J. V., Vendrig, L., & Rutten, G. E. H. M. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.05.019 · Cited by 29
Matía-Martín, P., Agudo, F. R., Medina, J. A., París, A. S., Tarazona‐Santabalbina, F. J., Pascual, J. R. D., Lopez‐Penabad, L., & Barriuso, R. S. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.05.007 · Cited by 27
Peng, J., Lu, J., Ma, X., Ying, L., Lu, W., Zhu, W., Bao, Y., & Zhou, J. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114518003628 · Cited by 25 · cited 1×
“To assess the clinical usefulness of LC-ONS, it is desirable to compare it with products that are clinically useful in patients with diabetes or prediabetes [33,34].”
BackgroundDevitt, A. A., Williams, J. A. S., Choe, Y. S., Hustead, D. S., & Mustad, V. A. (2013) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2013.49a001 · Cited by 17 · cited 1×
“Suppression of postprandial insulin secretion was observed with other ONS for diabetes [10,15,31] and low-glycemic index diets [32].”
BackgroundLaksir, H., Lansink, M., Regueme, S. C., den Bosch, J. D. V., Pfeiffer, A. F. H., & Bourdel‐Marchasson, I. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.09.027 · Cited by 17 · cited 1×
“In contrast, the ONS with 36% of the AC replaced with isomaltulose resulted in only a 15% reduction in postprandial blood glucose iAUC compared to a standard ONS with the same amount of AC [14].”
MethodAstina, J., Saphyakhajorn, W., Borompichaichartkul, C., & Sapwarobol, S. (2022) · Nutrients · doi:10.3390/nu14050916 · Cited by 17 · cited 1×
“As for the effect of soluble dietary fiber, the ONS with 23% of carbohydrates replaced with tapioca-derived resistant maltodextrin showed about 5% lower peak value of postprandial blood glucose than the standard ONS, but the difference was not significant [30].”
BackgroundBuranapin, S., Siangruangsang, S., Chantapanich, V., & Hengjeerajarus, N. (2014) · PubMed · Cited by 13
Huhmann, M. B., Smith, K. N., Schwartz, S. L., Haller, S., Irvin, S., & Cohen, S. S. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000240 · Cited by 6 · cited 2×
“There are three main strategies to suppress the postprandial blood glucose rise caused by ONS: (i) to reduce the energy proportion of available carbohydrates (AC, carbohydrates that are absorbed in the small intestine and increase blood glucose) and replace the energy with fat or protein [10,11]; (ii) using slowly dig…”
Background
Cited by
Hamamah, S., Iatcu, O. C., & Covașă, M. (2024) · Nutrients · doi:10.3390/nu16020269 · Cited by 43
“Numerous studies have supported the hypoglycemic effect of an LCD through decreased blood sugar and increased insulin sensitivity, leading to lowering oral antidiabetic medications, while also improving lipid parameters such as increased HDL cholesterol and decreased triglycerides [108–111].”
BackgroundHuang, S., Li, F., Quan, C., & Jin, D. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2423024 · Cited by 21
Gómez, J. J. L., Gutiérrez-Lora, C., Izaola-Jáuregui, O., Primo, D., Hoyos, E. G., Jiménez-Sahagún, R., & de Luis, D. A. (2022) · Nutrients · doi:10.3390/nu14224802 · Cited by 20
“These formulas can have the following characteristics: (a) the reduction of energy from carbohydrates and replace it with energy from lipids; (b) use of carbohydrates with a low glycemic index such as lactose or isomaltulose; or (c) increase the amount of soluble fiber to decrease glucose absorption [14].”
BackgroundMethodInfluentialDietary Fiber as Prebiotics: A Mitigation Strategy for Metabolic Diseases
Gao, X., Hu, S., Liu, Y., Alwis, S. A. S. S. D., Yu, Y., Li, Z., Wang, Z., & Liu, J. (2025) · Foods · doi:10.3390/foods14152670 · Cited by 18
“…oral dietary supplement consisting of SDF and slow-digesting isomaltulose (LC-ONS), patients who consumed LC-ONS had significantly lower blood glucose levels and an increased area under the insulin curve, demonstrating that slow-digesting DF reduced the rate of postprandial blood glucose rise [35].”
Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review
Dias, D. D., Vasconcelos, A. R., Souza, A. C. R., Menezes, C. D., Silva, I. S. T. E., & Name, J. J. (2025) · Obesities · doi:10.3390/obesities5040088 · Cited by 8
“In more recent trials with T2DM and prediabetic patients, fiber consumption was associated with reduced HbA1c and fasting glucose, increased microbiota diversity, and elevated insulin and C-peptide levels [127,128].”
Metadata
- Authors
- Kokubo, E., Morita, S., Nagashima, H., Oshio, K., Iwamoto, H., & Miyaji, K.
- Affiliations
- Morinaga (Japan) (JP)
- Medical Corporation Chiseikai Tokyo Center Clinic, 1-1-8 Yaesu, Chuou-ku, Tokyo 192-0397, Japan
- Corresponding author
- Kokubo, Eri
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2022-06-09
- Volume
- 14
- Issue
- 12
- Pages
- 2386
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC9227094
- OpenAlex
- W4282567826
- Cited by
- 13
- References
- 40
- Citations by year
- 2025: 5 · 2024: 5 · 2023: 1 · 2022: 2
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Morinaga Milk Industry Co., Ltd.
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Nursing › Nutrition and Dietetics › Food composition and properties
- Keywords
- isomaltulose, soluble dietary fiber, prediabetes, glycemic response, postprandial hyperglycemia, plasma insulin, energy supplementation
- MeSH terms
- Blood Glucose, Dietary Fiber, Glucose, Humans, Insulin, Isomaltose, Prediabetic State, Single-Blind Method, Cross-Over Studies, Postprandial Period
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.